HIV-infected Participants With ESRD Undergoing Routine Hemodialysis

Clinical trial pipeline · Data from ClinicalTrials.gov

See which HIV-infected Participants With ESRD Undergoing Routine Hemodialysis trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

CompletedPhase 4

NCT04689737

Removal of Doravirine by Hemodialysis in HIV-Infected Patients With End-stage Renal Disease (ESRD)

Doravirine is a novel non-nucleoside reverse transcriptase inhibitor that has demonstrated good efficacy, tolerability, and safety for the treatment of patients…

Spain8 participantsStarted 2021-03-20

Treatment: Doravirine